Rajesh Vij

Rajesh Vij

Active Director Director DIN 06426880
DIN 06426880 First appointment Nov 2012 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2012
Shareholding value •••• Premium profile

About Rajesh Vij

Data last updated:

Rajesh Vij is a Director at Neurochem Laboratories Private Limited (since 2012). The company operates in Healthcare. Neurochem Laboratories Private Limited reported revenue of ₹5.12 Cr (FY 2025).

DIN 06426880
Primary Designation Director
Industry Healthcare
First Appointment 16 Nov 2012
Oldest Company Age 13 yrs
Largest company Neurochem Laboratories Private Limited · ₹5.12 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Nov 20122012₹5.12 Cr (FY 2025)Active

Board colleagues of Rajesh Vij

NameDINCompanyDesignation
Hemant Vij06426874Neurochem Laboratories Private LimitedDirector

Directorship timeline

Open interactive timeline →
Neurochem Laboratories Private Limited
Premium access

Shareholding and investment profile for Rajesh Vij

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Vij

Rajesh Vij currently holds 1 directorship: Neurochem Laboratories Private Limited (Director, since 16 Nov 2012, revenue ₹5.12 Cr (FY 2025)).

Rajesh Vij was first appointed on 16 Nov 2012 as Director at Neurochem Laboratories Private Limited.

The current boards of Rajesh Vij's companies include Hemant Vij (Neurochem Laboratories Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available